These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10319741)

  • 1. Measuring reproducibility of regional brain metabolic responses to lorazepam using statistical parametric maps.
    Wang GJ; Volkow ND; Levy AV; Felder CA; Fowler JS; Pappas NR; Hitzemann RJ; Wong CT
    J Nucl Med; 1999 May; 40(5):715-20. PubMed ID: 10319741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility of regional brain metabolic responses to lorazepam.
    Wang GJ; Volkow ND; Overall J; Hitzemann RJ; Pappas N; Pascani K; Fowler JS
    J Nucl Med; 1996 Oct; 37(10):1609-13. PubMed ID: 8862292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional brain metabolism during alcohol intoxication.
    Wang GJ; Volkow ND; Franceschi D; Fowler JS; Thanos PK; Scherbaum N; Pappas N; Wong CT; Hitzemann RJ; Felder CA
    Alcohol Clin Exp Res; 2000 Jun; 24(6):822-9. PubMed ID: 10888070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of gender difference in regional brain metabolic responses to lorazepam.
    Wang GJ; Volkow ND; Fowler JS; Hitzemann RJ; Pappas NR; Netusil N
    Psychiatry Res; 1998 Apr; 82(1):37-46. PubMed ID: 9645549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional brain metabolic response to lorazepam in alcoholics during early and late alcohol detoxification.
    Volkow ND; Wang GJ; Overall JE; Hitzemann R; Fowler JS; Pappas N; Frecska E; Piscani K
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1278-84. PubMed ID: 9347090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effect of 3-(4-acetamido)-butyrril-lorazepam (DDS2700) on brain function assessed by PET at rest and during attentive tasks.
    Moresco RM; Tettamanti M; Gobbo C; Del Sole A; Ravasi L; Messa C; Paulesu E; Lucignani G; Perani D; Fazio F
    Nucl Med Commun; 2001 Apr; 22(4):399-404. PubMed ID: 11338050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping.
    Kawasaki K; Ishii K; Saito Y; Oda K; Kimura Y; Ishiwata K
    Ann Nucl Med; 2008 Apr; 22(3):191-200. PubMed ID: 18498034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thalamus as the generator and modulator of EEG alpha rhythm: a combined PET/EEG study with lorazepam challenge in humans.
    Schreckenberger M; Lange-Asschenfeldt C; Lochmann M; Mann K; Siessmeier T; Buchholz HG; Bartenstein P; Gründer G
    Neuroimage; 2004 Jun; 22(2):637-44. PubMed ID: 15193592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study.
    Volkow ND; Wang GJ; Fowler JS; Hitzemann R; Gatley SJ; Dewey SS; Pappas N
    Am J Psychiatry; 1998 Feb; 155(2):200-6. PubMed ID: 9464198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in cerebellar metabolism: test-retest reproducibility.
    Volkow ND; Wang GJ; Fowler JS; Hitzemann R; Pappas N; Pascani K; Wong C
    Am J Psychiatry; 1997 Jan; 154(1):119-21. PubMed ID: 8988972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased cerebral response to inhibitory neurotransmission in alcoholics.
    Volkow ND; Wang GJ; Hitzemann R; Fowler JS; Wolf AP; Pappas N; Biegon A; Dewey SL
    Am J Psychiatry; 1993 Mar; 150(3):417-22. PubMed ID: 8382010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping.
    Signorini M; Paulesu E; Friston K; Perani D; Colleluori A; Lucignani G; Grassi F; Bettinardi V; Frackowiak RS; Fazio F
    Neuroimage; 1999 Jan; 9(1):63-80. PubMed ID: 9918728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional stereotactic surface projection analysis of macaque brain PET: development and initial applications.
    Cross DJ; Minoshima S; Nishimura S; Noda A; Tsukada H; Kuhl DE
    J Nucl Med; 2000 Nov; 41(11):1879-87. PubMed ID: 11079499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of different methods for attenuation correction in brain PET: effect on the calculation of the metabolic rate of glucose].
    Setani K; Schreckenberger M; Sabri O; Meyer PT; Zeggel T; Büll U
    Nuklearmedizin; 2000; 39(2):50-5. PubMed ID: 10768170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of statistical parametric mapping of (18) F-FDG-PET in frontal lobe epilepsy.
    Plotkin M; Amthauer H; Merschhemke M; Lüdemann L; Hartkop E; Ruf J; Gutberlet M; Bertram H; Meencke HJ; Felix R; Venz S
    Nuklearmedizin; 2003 Oct; 42(5):190-6. PubMed ID: 14571315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral glucose metabolism during pharmacologic studies: test-retest under placebo conditions.
    Schmidt ME; Ernst M; Matochik JA; Maisog JM; Pan BS; Zametkin AJ; Potter WZ
    J Nucl Med; 1996 Jul; 37(7):1142-9. PubMed ID: 8965185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral glucose metabolism in patients with frontotemporal dementia.
    Ishii K; Sakamoto S; Sasaki M; Kitagaki H; Yamaji S; Hashimoto M; Imamura T; Shimomura T; Hirono N; Mori E
    J Nucl Med; 1998 Nov; 39(11):1875-8. PubMed ID: 9829574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.